Standout Papers

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failu... 2020 2026 2022 2024219
  1. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure (2020)
    Jordan Gauthier, Alexandre V. Hirayama et al. Blood

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
Past, present, and future of CRISPR genome editing technologies
2024 Standout
2 intermediate papers

Works of Daniel H. Li being referenced

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
2020 Standout

Author Peers

Author Last Decade Papers Cites
Daniel H. Li 98 57 25 189 97 12 407
Tom Hofland 206 22 8 225 179 18 422
Anne W. J. Martens 241 37 7 187 95 12 381
Marianne Asso‐Bonnet 79 105 60 102 33 9 368
Scott Melvin 81 27 1 149 76 10 441
West Wh 168 37 6 164 32 12 389
Alessandro Previtali 70 15 2 239 38 17 341
Lanier H. Ayscue 46 56 26 95 86 11 389
Francis Lopez 71 27 5 123 39 11 392
G. W. Löhr 119 19 10 77 69 18 385
Fanny Angelot‐Delettre 133 87 5 226 23 20 401

All Works

Loading papers...

Rankless by CCL
2026